In the CIA rat model, TY treatment alleviated arthritis symptoms, reduced paw swelling and bone erosion, improved joint pathology, decreased serum levels of IL-1β, IL-18, and TNF-α, and suppressed the expression of key proteins involved in the NLRP3 inflammasome-mediated pyroptosis pathway in synovial tissue. Here, NLRP3 is linked to arthritic joint disease.